Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Harth

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Agents and Actions. Supplements|January 1, 1988
Auranofin in rheumatoid arthritis: what variables could affect the clinical response?M Harth
The Journal of Rheumatology. Supplement|January 1, 1992
Mechanisms of action of disease modifying antirheumatic drugsM Harth
The Journal of Rheumatology|May 1, 1993
Gold in rheumatoid arthritis: standard, substitute or sham?M Harth
The Journal of Rheumatology. Supplement|January 1, 1979
Gold and modulation of the immune responseM Harth
Agents and Actions. Supplements|January 1, 1981
Modulation of immune responses of gold saltsM Harth
Arthritis and Rheumatism|March 1, 1975
Letter: Serum gold levelsM Harth
Arthritis and Rheumatism|January 1, 1994
Effects of gold on interleukin-2 and interleukin-2 receptor: comment on the article by Sfikakis et alM Harth
Clinical Pharmacology and Therapeutics|April 1, 1974
Serum gold levels during chrysotherapy with relation to urinary and fecal excretionM Harth
Rheumatology (Oxford, England)|January 24, 2004
Comment on 'Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting.' by Hazemeijer and RaskerM Harth, W Nielson
Rheumatology (Oxford, England)|October 14, 2004
The measure of our measuresM Harth, J Pope
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Agents and Actions. Supplements|January 1, 1988
Auranofin in rheumatoid arthritis: what variables could affect the clinical response?M Harth
The Journal of Rheumatology. Supplement|January 1, 1992
Mechanisms of action of disease modifying antirheumatic drugsM Harth
The Journal of Rheumatology|May 1, 1993
Gold in rheumatoid arthritis: standard, substitute or sham?M Harth
The Journal of Rheumatology. Supplement|January 1, 1979
Gold and modulation of the immune responseM Harth
Agents and Actions. Supplements|January 1, 1981
Modulation of immune responses of gold saltsM Harth
Arthritis and Rheumatism|March 1, 1975
Letter: Serum gold levelsM Harth
Arthritis and Rheumatism|January 1, 1994
Effects of gold on interleukin-2 and interleukin-2 receptor: comment on the article by Sfikakis et alM Harth
Clinical Pharmacology and Therapeutics|April 1, 1974
Serum gold levels during chrysotherapy with relation to urinary and fecal excretionM Harth
Rheumatology (Oxford, England)|January 24, 2004
Comment on 'Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting.' by Hazemeijer and RaskerM Harth, W Nielson
Rheumatology (Oxford, England)|October 14, 2004
The measure of our measuresM Harth, J Pope
Pageof 12